A key step in the development of the cerebral cortex is a patterning process, which subdivides the telencephalon into several molecularly distinct domains and is critical for cortical arealization. This process is dependent on a complex network of interactions between signaling molecules of the Fgf and Wnt gene families and the Gli3 transcription factor gene, but a better knowledge of the molecular basis of the interplay between these factors is required to gain a deeper understanding of the genetic circuitry underlying telencephalic patterning. Using DNA-binding and reporter gene assays, we here investigate the possibility that Gli3 and these signaling molecules interact by directly regulating each other's expression. We show that Fgf signaling is required for Wnt8b enhancer activity in the cortical hem, whereas Wnt/β-catenin signaling represses Fgf17 forebrain enhancer activity. In contrast, Fgf and Wnt/β-catenin signaling cooperate to regulate Gli3 expression. Taken together, these findings indicate that mutual interactions between Gli3, Wnt8b, and Fgf17 are crucial elements of the balance between these factors thereby conferring robustness to the patterning process. Hence, our study provides a framework for understanding the genetic circuitry underlying telencephalic patterning and how defects in this process can affect the formation of cortical areas.
Introduction
A patterning process subdividing the telencephalon into several distinct domains represents a key step in the development of the cerebral cortex which performs highly complex neural tasks. This process is thought to be critically dependent on a complex network of interactions between intercellular signaling molecules and transcription factors. Signaling molecules of the Fgf, Wnt, and Bmp gene families act as morphogens to determine rostrodorsal and dorsomedial telencephalic cell fates (Machon et al. 2007; Mangale et al. 2008; Toyoda et al. 2010) , respectively, by directly controlling the expression of transcription factors (Theil et al. 2002; Suda et al. 2010) . In turn, these factors regulate not only the expression of genes involved in cell fate determination and in controlling proliferation/differentiation of cortical progenitor cells, but also that of the signaling molecules themselves thereby setting up feedback loops between signaling molecules and transcription factors (Theil et al. 2002; Muzio et al. 2005; Saulnier et al. 2013) . Moreover, the signaling molecules have been shown to autoregulate their own expression (HasenpuschTheil et al. 2012) or to repress each other's expression (Ohkubo et al. 2002; Shimogori et al. 2004; Storm et al. 2006) . Collectively, these complex interactions are used to establish and to maintain distinct gene expression territories in the developing telencephalon as a prerequisite for patterning.
Interactions between Fgfs and Bmps/Wnts are a crucial element in the model outlined above. Analyses of mutant mice and studies in chicken embryos have revealed that the disruption of a tight balance between Fgfs and Bmp/Wnts leads to severe defects in dorsal telencephalic development (Crossley et al. 2001; Ohkubo et al. 2002; Shimogori et al. 2004; Storm et al. 2006) . A key factor in regulating this balance is the Gli3 zinc finger transcription factor. In the dorsal telencephalon, the Gli3 repressor form predominates (Fotaki et al. 2006 ) to inhibit Sonic hedgehog (Shh) signaling, but it also represses the expression of multiple Fgf family members (Fgf8/15/17/18) and is required for the expression of Bmp2/4/6 and Wnt3a/7b/8b (Grove et al. 1998; Theil et al. 1999; Kuschel et al. 2003; Rash and Grove 2007) . Absence or reduced levels of Gli3 result in the upregulation of these Fgfs and in a downregulation of Bmp/Wnt gene expression. These changes severely affect telencephalic patterning (Grove et al. 1998; Theil et al. 1999; Tole et al. 2000; Kuschel et al. 2003) and also later processes in cortical development such as the formation of the corpus callosum (Benadiba et al. 2012; Amaniti et al. 2013; Magnani et al. 2014) . These findings therefore emphasize the importance of a tightly controlled balance between Gli3, Fgfs, and Bmps/Wnts for normal cortical development. However, these interactions are mainly derived from genetic analyses and very little is known about their molecular basis. A better knowledge of the interactions at the molecular level is required for a deeper understanding of the molecular and genetic circuitry underlying telencephalic patterning.
Here, we explore the possibility that Wnts, Fgfs, and Gli3 regulate each other's expression through direct transcriptional regulation. Using DNA-binding and reporter gene assays and overexpression experiments, we show that a Wnt8b dorsomedial telencephalon enhancer contains an essential binding site for Ets transcription factors, transcriptional mediators of Fgf signaling. Mutation of this site results in loss of lacZ reporter gene expression in the cortical hem. In turn, a binding site for Tcf transcription factors is required to repress the activity of an Fgf17 forebrain enhancer in the dorsomedial telencephalon. Moreover, we show that the activity of a Gli3 dorsal telencephalon enhancer depends on Fgf signaling. Mutations of an Ets-binding site within this enhancer abolish its activity in the dorsomedial telencephalon. Interestingly, this Ets site flanks a Tcf-binding site which we previously showed to be essential for Gli3 enhancer activity (Hasenpusch- . Indeed, the presence of Etv4 protein increases the binding of Lef1 to the Gli3 enhancer in electromobility shift assays (EMSAs). Taken together, these findings suggest complex and direct interactions between Gli3, Wnt8b, and Fgf17 including direct (i) mutual interactions between Wnt and Fgf signaling and (ii) a cooperative interaction between these signaling pathways to regulate Gli3 expression.
Materials and Methods

Mice
Gli3
Xt/+ and Gli3 Pdn/+ animals were kept on a mixed C57Bl6/C3H
and C3H background, respectively, and were interbred. Embryonic (E) day 0.5 was assumed to start at midday of the day of vaginal plug discovery. Embryos were genotyped as described (Maynard et al. 2002; Ueta et al. 2002) . For in situ hybridization, Gli3 Xt/+ ,
Pdn/+ , and wild-type embryos, which did not show differences, were used as control embryos and forebrain morphology was used to distinguish them from Gli3
Xt/Pdn and Gli3 Pdn/Pdn embryos (Kuschel et al. 2003) . Emx1Cre and Gli3 flox/flox mouse lines have been described previously (Gorski et al. 2002; Blaess et al. 2008) . For Emx1Cre;Gli3 flox/flox conditional embryos, Gli3 flox/flox , Gli3 flox/+ , Emx1Cre, and Gli3 flox/+ embryos were used as controls. All experimental procedures involving mice were performed in accordance with local guidelines. For each marker and each stage, 3-5 embryos were analyzed.
In Situ Hybridization, Immunohistochemistry, and X-Gal Staining on Sectioned Embryonic Brains
In situ hybridization on 10 μm coronal paraffin sections of E12.5 mouse brains was performed as described previously (Theil 2005) . Digoxigenin-labeled antisense probes were generated from the following cDNA clones: Fgf15 (McWhirter et al. 1997) , Fgf17 (Xu et al. 1999) , and Fgf18 (Hasegawa et al. 2004 ).
For the reporter gene analysis of in utero electroporated embyros, brains were dissected in PBS and fixed for 3 h in 4% PFA. After embedding in OCT/sucrose, 14 μm coronal cryosections were analyzed by immunofluorescence using an antibody against GFP (1 : 1000; Abcam), followed by a nuclear counterstain with TO-PRO-1 (1 : 3000, Invitrogen), as described previously (Hasenpusch-Theil et al. 2012) . Adjacent sections were stained with X-Gal at 37°C and counterstained with Fast RED (Hasenpusch-Theil et al. 2012 ).
Plasmid Construction and Mutagenesis
All genomic DNA fragments were generated via PCR using wildtype genomic DNA (for oligonucleotides, see Supplementary  Table 1 ). Enhancer sequences were subcloned using a TOPO TA cloning kit (Invitrogen) and verified by sequencing. Putative TCF/Lef1-and Ets-binding sites were mutated using the QuickChange Site-Directed Mutagenesis Kit (Stratagene; for oligonucleotides used in mutagenesis, see Supplementary Table 2 ). All mutations were confirmed by sequencing. To test for enhancer activity, wild-type and mutant regulatory elements were subcloned into the lacZ reporter gene vector pGZ40 upstream of a human β-globin minimal promoter (Yee and Rigby 1993) . For generating transgenic embryos, the enhancer/reporter fragment was released from the plasmid backbone by digestion with the restriction enzymes indicated in Supplementary Table 1 and gel  purified. For the Etv4 activator and repressor constructs, the Etv4 DNAbinding domain was PCR-amplified using the forward oligonucleotide 5′-CAGCGTCGTGGCTCACTTC-3′ and the reverse oligonucleotide 5′-AATACTAGTAAAGCTTCTGGCTCACACAC-3′. The resulting PCR fragment was subcloned into pCS2+ vector upstream and in frame of either the engrailed repressor domain or the E1A activator domain (Bellefroid et al. 1996) .
Electrophoretic Mobility Shift Assay
Electrophoretic mobility assays for the Wnt8b and Gli3 enhancers were performed with radioactively labeled oligonucleotides using purified GST, GST-Etv4 (Greenall et al. 2001) , and GSTLef1 as described previously (Theil et al. 2002) . For the Fgf17 enhancers, biotin-labeled oligonucleotides were used for bandshift analysis. The binding reaction was separated on native 5% acrylamide gels and transferred onto positively charged nylon membranes (Roche) with a Perfect Blue Semi-dry electro-blotter (60 min at 120 V, 5 mA). After UV crosslinking, biotin-labeled probes were detected using a Chemiluminescent Nucleic Acid Detection Module (Thermo Scientific #89880) according to manufacturer's instructions and imaged using a Kodak BioMaxXAR film.
For oligonucleotide sequences covering the wild-type or mutated Etv4-and Tcf/Lef-binding sites, see Supplementary  Table 3 . The exchanged nucleotides in the mutated forms are underlined. Wild-type, Ets-, and Tcf/Lef-binding site mutant oligonucleotides were used as specific and unspecific competitors, respectively, in a 10-to 100-fold molar excess.
Transgenic Embryos
Transgenic embryos were generated by microinjection of fertilized eggs from B6CBAF1/Crl crosses (Charles River) and were identified by PCR using extra-embryonic yolk sac or tail DNA.
Expression of the transgene was analyzed by staining E10.5 or E11.5 embryos for β-galactosidase activity as described previously (Theil et al. 1998 ).
In Utero Electroporation E12.5 pregnant mice were anesthetized with sodium pentobarbitone at 50 mg per gram of body weight and the uterine horns were exposed. LacZ reporter gene plasmids, a GFP expression plasmid, and Etv4 repressor/activator plasmids were coinjected into the lateral ventricle at 1 mg/mL each with a glass micropipette. The embryo in the uterus was placed between CUY650 tweezer-type electrodes (Nepagene). A CUY21E electroporator (Nepagene) was used to deliver 6 pulses (30 V, 50 ms each) at intervals of 950 ms. The uterine horns were placed back into the abdominal cavity and embryos were allowed to develop for 24 h before further processing for immunofluorescence. For each construct and time point, at least 4 different embryos were analyzed.
Explant Culture
Organotypic slice cultures of the E13.5 embryonic mouse telencephalon were prepared as previously described (Magnani et al. 2010 ). Brain slices were cultured on polycarbonate culture membranes (8 μm pore size; Corning Costar) in organ tissue dishes containing 1 mL of medium (Neurobasal/B-27 [Gibco] supplemented with glutamine, glucose, penicillin, and streptomycin) in the presence of either DMSO or of 25 or 50 μM CHIR (Cambridge BioScience). Slices were cultured for 24 h, fixed with 4% PFA, and processed for in situ hybridization as described above.
Results
Interactions between Gli3, Fgfs, and Wnts/Bmps play an important role in controlling telencephalic patterning. To gain insights into the molecular mechanisms underlying these interactions, we examined the transcriptional regulation of Gli3 and of members of the Fgf and Wnt gene families. We used sequence analyses of regulatory elements controlling forebrain expression of Gli3, Fgfs, or Wnt8b to identify potential binding sites for Ets and Tcf/ Lef transcription factors, transcriptional mediators of Fgf and Wnt/β-catenin signaling, respectively. We then tested the functionality of these binding sites in DNA-binding and reporter gene assays.
Fgf Signaling Controls Cortical Hem Activity of the Wnt8b Dorsomedial Telencephalon Enhancer
An ultraconserved enhancer element located between Wnt8b and Sec31b drives expression of a lacZ reporter gene in the dorsomedial telencephalon in a pattern highly similar to that of the Wnt8b gene (Hasenpusch-Theil et al. 2012; Visel et al. 2013; Pattabiraman et al. 2014) . We recently showed that this element contains an essential binding site for Lef/Tcf transcription factors, suggesting that Wnt8b autoregulates its own expression (Hasenpusch- . Here, we investigated the possibility that Fgf signaling directly regulates the activity of the Wnt8b dorsomedial telencephalon enhancer. Fgf signaling results in the activation of Ets transcription factors that bind to a purine rich 8 bp-binding motif ( C / G / A AGGAA G / A T) (Hollenhorst et al. 2007 ).
Interestingly, the Wnt8b enhancer contains an evolutionarily conserved AAGGAAAT/ C motif, which closely resembles this consensus sequence. We therefore determined whether an Ets transcription factor can bind to this sequence from the Wnt8b enhancer in EMSAs. During cortical development, Etv1, Etv4, and Etv5 that belong to the same subclass of Ets transcription factors with nearly identical DNA-binding specificities (Wei et al. 2010) are highly expressed in the rostromedial telencephalon (Zimmer et al. 2010) . Since the full-length Etv proteins contain an inhibitory domain which interferes with DNA binding, and since this inhibition is only relieved upon Fgf/Map Kinase signaling, we used a previously described glutathione-S-transferase fusion protein (GST-Etv4) containing just the Etv4 DNA-binding domain but not the inhibitory domain in the DNA-binding assay (Greenall et al. 2001 ). Incubation of GST-Etv4 with an oligonucleotide containing the Ets motif from the Wnt8b enhancer resulted in the formation of a slower migrating complex (Fig. 1A) .
To further analyze the specificity and affinity of DNA-binding, competition assays were conducted in the presence of various surplus unlabeled wild-type oligonucleotide (competitor), which resulted in progressively diminished binding of GST-Etv4 fusion protein with an increasing amount of competitor. However, the formation of this complex was not competed by unlabeled Wnt8b competitor oligonucleotide containing an AGG to CTT exchange, which abolishes Ets binding (Lettice et al. 2012 ). Thus, GST-Etv4 specifically bound to the Ets-binding site within the Wnt8b dorsomedial telencephalon enhancer.
The role of the Ets-binding site in regulating the Wnt8b enhancer activity in vivo was determined by generating the same point mutations used in the EMSA analyses in the Ets-binding site within the Wnt8b enhancer. Reporter gene constructs containing either the wild-type or Ets mutant enhancers fused to a lacZ reporter gene under the control of a human β-globin minimal promoter (Yee and Rigby 1993) were used to generate transgenic embryos. In E11.5 embryos, transgenic for a Wnt8b enhancer/ lacZ transgene X-Gal staining was detected in the cortical hem, in progenitor cells of the dorsomedial telencephalon, and in preplate neurons (n = 5/7 transgenic embryos; Fig. 1B,C) . Mutations in the Ets-binding site resulted in similar reporter gene expression in cortical progenitor cells and in preplate neurons, although lacZ+ neurons were detected at the level of the ventral telencephalon (n = 5/7; Fig. 1G ,H). In contrast, lacZ staining was abolished in the cortical hem (n = 5/7), suggesting that the Ets-binding site is specifically required for Wnt8b enhancer activity in the hem.
To further explore the possibility that Fgf signaling regulates hem Wnt8b expression, we coelectroporated the Wnt8b enhancer construct with Etv4 expression constructs in which the Etv4 DNA-binding domain was fused either to an engrailed repressor (Etv4-EngR) or an Adenovirus E1A activator domain (Etv4-E1A) into the rostromedial telencephalon. The resulting fusion proteins have the Etv4 DNA-binding domain, but act as a transcriptional repressor and activator of Etv4 target genes, respectively. Electroporation of just the Wnt8b enhancer/lacZ reporter construct into the rostromedial telencephalon resulted in strong XGal staining in electroporated cells in the ventral rostromedial telencephalon (n = 5 electroporated embryos) but not in more dorsal regions, despite strong electroporation in this area (Fig. 1D,I ). Coelectroporation of the Etv4-E1A expression construct resulted in the robust activation of the reporter in a dorsally expanded domain (n = 6 electroporated embryos; Fig. 1E,J) . In contrast, we only detected weakly X-Gal+ cells confined to the rostroventral telencephalon after coelectroporation of the Etv4-EngR construct (n = 5 electroporated embryos) despite similar electroporation efficiencies (Fig. 1F,K) . Taken together, these data indicate that Etv transcription factor can bind to an essential site within the Wnt8b enhancer and regulate its activity in the cortical hem.
Expression of Several Fgf Family Members s Differentially Regulated in Gli3 Mutants
We next analyzed how the forebrain expression of Fgf genes is regulated. Several Fgfs, including Fgf8, Fgf15, Fgf17, and Fgf18, show overlapping but distinct expression patterns in the rostral telencephalon. To investigate whether their expression might be regulated by Gli3, Bmp, and/or Wnt/β-catenin signaling, we first analyzed their expression in various Gli3 mutants in which Bmp/Wnt gene expression is differentially affected. The Gli3 compound mutant Gli3
Xt/Pdn carries the Gli3 null allele extra-toes (Xt  J ) over the Gli3 hypomorphic allele Polydactyly Nagoya (Pdn) and shows severely reduced Bmp signaling and a lack of Wnt/β-catenin signaling in the dorsomedial telencephalon, while the Gli3 hypomorphic mutant Gli3 Pdn/Pdn displays reduced activity of the Bmp and Wnt/β-catenin pathways (Kuschel et al. 2003; Friedrichs et al. 2008; Magnani et al. 2014) . In contrast, Emx1Cre;Gli3 fl/fl (Gli3 cKO ) embryos in which Gli3 is specifically inactivated in the dorsal telencephalon show normal Bmp4 and Wnt7b/8b gene expression at the E12.5 corticoseptal boundary (CSB), but show reduced Bmp/Wnt gene expression in the caudal cortical hem (Hasenpusch-Theil et al. 2012; Amaniti et al. 2013 ). Comparing Fgf gene expression patterns in these different Gli3 mutants therefore provided us with first insights whether Gli3, Bmps, and/or Wnts could regulate Fgf gene expression. Fgf8 is the major Fgf signaling molecule with crucial roles in telencephalic development (Hebert and Fishell 2008; Borello and Pierani 2010) . Its expression is confined to the commissural plate (CP) in E12.5 control embryos and expands caudomedially in Gli3
Xt/Pdn and Gli3 Pdn/Pdn embryos (Kuschel et al. 2003) but not in Gli3 cKO embryos (Amaniti et al. 2013) , suggesting that Fgf8 expression is repressed by Gli3 in a Bmp-and/or Wnt/β-catenin-dependent manner. Fgf18 expression is also detected in the CP, but extends further rostrally into the septum with a sharp expression boundary at the CSB. Fgf18 expression is not affected in Gli3 mutants ( Supplementary Fig. 1 ), indicating that its expression is not regulated by these pathways. In contrast, Fgf17 is expressed in the septum and at low levels in the roof plate ventral to the cortical hem of control embryos ( Fig. 2A -C,G-I) but shows ectopic expression in the cortical hem and adjacent hippocampal primordium of all 3 Gli3 mutants, while its septal expression is not affected (Fig. 2D -F,J-L), suggesting that Fgf17 expression in the dorsomedial telencephalon is repressed in a Gli3-dependent manner likely through Bmp and/or Wnt/β-catenin signaling. Finally, Fgf15 has the widest Fgf expression domain encompassing the septum and the interganglionic sulcus, while the cortical primordium is devoid of Fgf15 transcripts (Fig. 2M -O,S-U). In contrast, all Gli3 mutants show a dramatic up-regulation of Fgf15 expression in cortical progenitors (Fig. 2P -R,V-X), strongly suggesting that its cortical expression is repressed by Gli3. Taken together, these findings suggest that the partially overlapping but distinct expression patterns of Fgfs in the telencephalon are generated by differential regulation through Gli3, Bmps, and/or Wnts signalling.
Activity of an Fgf17 Forebrain Enhancer Is Repressed by Wnt/β-Catenin Signalling
Next, we investigated the molecular basis for this differential regulation by analyzing regulatory elements directing Fgf gene expression in the forebrain. Fgf8 expression is controlled by multiple and distinct regulatory modules that act in a holo-enhancer as a coherent unit (Marinic et al. 2013 ) and this control can only be studied within the context of the holo-enhancer. The regulation of Fgf18 is less well characterized, and there is currently no regulatory element available directing Fgf18 expression. A 3.5-kb region immediately upstream of the Fgf15 promoter was shown to direct lacZ reporter gene expression in the diencephalon and midbrain of E9.5 transgenic mouse embryos and to contain a Gli-binding site essential for its activity (Saitsu et al. 2005; . However, our in utero electroporation showed that this element is not active in the E13.5 dorsomedial and dorsolateral telencephalon and mutations in the Gli-binding site did not result in enhancer activity in the dorsal telencephalon either (Supplementary Fig. 2) . Thus, Fgf15 expression in the telencephalon is regulated by currently unknown regulatory elements located outside this 3.6 kb region.
Finally, 2 evolutionarily conserved Fgf17 regions were shown to control lacZ reporter expression in the forebrain (Visel et al. 2008 ). An intragenic Fgf17 enhancer (Vista Enhancer element # 782) shows specific activity in the septum, whereas an enhancer (Vista Enhancer element # 781) located in the intergenic region between Fgf17 and Epb4.9, which is not expressed in the telencephalon, is active in the telencephalic roof plate as well as in the septum (Supplementary Fig. 3 ). Since these 2 enhancers accurately reflect expression of the endogenous Fgf17 gene, they were used for further analysis. Sequence inspection revealed a single evolutionarily conserved Tcf/Lef-binding site in both enhancers; however, a recombinant full-length Lef1 protein fused to glutathione-S-transferase (GST-Lef1) only bound to the intergenic Fgf17 enhancer but not to the Fgf17 intragenic regulatory element in EMSAs ( Supplementary Fig. 4 ). Binding to the oligonucleotide from the intragenic enhancer was specific as it was competed by unlabeled wild-type oligonucleotide but not by 1 containing 2 point mutations which abolish Lef1 binding (Hasenpusch-Theil et al. 2012; Fig. 3A) . We next tested the functionality of this Tcf/Lef-binding site within the Fgf17 intragenic enhancer by electroporating a wild-type Fgf17/lacZ (Fgf17/lacZ) and a Tcf mutant Fgf17/lacZ (mTcfFgf17/lacZ) reporter gene construct into the telencephalon. Electroporations of the Fgf17/lacZ construct resulted in X-Gal staining in the septum (n = 5/6 embryos) but not in the cortex (n = 0/4 embryos) or in the hippocampal primordium (n = 0/6 embryos; Fig. 3B-E ) reflecting the expression of the endogenous Fgf17 gene. In the rostral telencephalon, the mTcfFgf17/lacZ construct showed an identical activity pattern with lacZ staining in the septum (n = 5/5 embryos) but not in the cortex (n = 0/3 embryos; Fig. 3F,G) . In contrast, the mutant construct was ectopically active in the cortical hem and in the hippocampus (n = 5/6 embryos; Fig. 3H,I ) where Fgf17 is ectopically expressed in Gli3 mutant but not in wild-type embryos. These findings suggest that Wnt/β-catenin signaling represses the activity of the intergenic Fgf17 enhancer in the cortical hem and hippocampus.
To obtain further evidence for the ability of Wnt/β-catenin signaling to regulate Fgf17 expression, we determined the consequences of ectopic activation of this pathway on endogenous Fgf17 expression. To this end, we employed an ex vivo explant assay (Hasenpusch-Theil et al. 2012 ) in which we prepared coronal sections of the E13.5 mouse telencephalon and maintained these sections in culture for 24 h in the presence of DMSO or various concentrations of CHIR99021 (CHIR), which selectively inhibits GSK3β and thereby activates Wnt/β-catenin signaling (Ring et al. 2003) . Under control conditions, Fgf17 expression is confined to the CP (Fig. 3J ). This expression pattern is maintained in the presence of 25 μm CHIR (Fig. 3K ), but treatment with 50 μm CHIR led to a severe reduction in Fgf17 expression (Fig. 3L) . These findings indicate that Fgf17 expression can be repressed by Wnt/β-catenin signaling. 
Fgf and Wnt/β-Catenin Signaling Cooperate to Control the Activity of a Gli3 Forebrain Enhancer in the Dorsomedial Telencephalon and in the Thalamus
Finally, we analyzed the transcriptional regulation of Gli3. Our previous analyses showed that the activity of a Gli3 forebrain enhancer is directly regulated by Wnt/β-catenin signaling (Hasenpusch-Theil et al. 2012) . Close examination of the enhancer sequences also identified 4 evolutionarily conserved A / G-AGGAA A / G G / A motifs in the Gli3 forebrain enhancer, raising the possibility that Ets transcription factors and hence Fgf signaling could regulate Gli3 enhancer activity. Oligonucleotides containing the predicted Ets-binding motifs were therefore tested for binding to GST-Etv4 in EMSAs. In this assay, GST-Etv4 specifically bound to all 4 Ets-binding sites showing, however, different affinities with sites 1 and 4 showing the strongest and site 3 the weakest binding (Fig. 4) . We next tested whether these sites are essential for Gli3 forebrain enhancer activity by generating transgenic reporter gene embryos containing point mutations in these sites to abolish Ets binding. The wild-type Gli3 enhancer directed strong reporter gene expression in E11.5 telencephalon and in the thalamus as described previously (Paparidis et al. 2007; Visel et al. 2008; Hasenpusch-Theil et al. 2012 ; Fig. 5A ). In contrast, a construct containing mutations in all 4 Ets-binding sites led to reduced and patchy lacZ expression in the dorsomedial telencephalon and to a complete loss of enhancer activity in the thalamus, whereas expression in the dorsolateral telencephalon is not affected (n = 5/9 transgenic embryos; Fig. 5B ). To analyze the individual contributions of these sites, we tested Gli3 enhancer activity after introducing mutations in combinations of the Etsbinding sites. Intact-binding sites 3 and 4 were not sufficient to restore enhancer activity as constructs containing intact Etsbinding sites 3 or 3+4, but mutations in sites 1 and 2 still showed loss of enhancer activity in the dorsomedial telencephalon and in the thalamus (n = 5/9 transgenic embryos for each construct; Fig. 5C,D) , suggesting that binding sites 1 and 2 are essential for this enhancer activity. We therefore tested the contribution of binding sites 1 and 2 by individually mutating these 2 sites. In contrast to a binding site 1 mutant construct which produced the wild-type lacZ expression pattern (n = 2/4 transgenic embryos; Fig. 5E ), embryos transgenic for the binding site 2 mutant construct showed a loss of enhancer activity in dorsomedial telencephalon and in the thalamus (n = 5/10 transgenic embryos; Fig. 5F ). In addition, we noted that embryos transgenic for constructs lacking site 2 but with an intact site 3 have a broader loss of enhancer activity in the dorsomedial telencephalon (Fig. 5C,D,F) , suggesting that site 3 might repress the activity of site 2. Thus, Ets-binding site 2 is crucial for Gli3 forebrain enhancer activity in these tissues, whereas binding site 3 might have a modulatory effect on the activity of site 2. Interestingly, Ets-binding site 2 lies immediately adjacent to the essential Tcf/Lef-binding site we previously identified (Hasenpusch-Theil et al. 2012) , raising the possibility that Ets and Tcf/Lef transcription factors might cooperate in regulating the Gli3 forebrain enhancer. To test this possibility, we performed EMSA analyses with an oligonucleotide containing the Tcf/Lef and Ets-binding site 2 and recombinant GST-Lef1 and/or GST-Etv4 fusion protein. Incubation with the single proteins led to the formation of a single complex (Fig. 6) . The formation of the GST-Lef1 complex, however, was increased in the presence of both proteins (Fig. 6) , suggesting that Etv4 increases the binding affinity for Lef1 to its binding site within the Gli3 forebrain enhancer.
Discussion
The Gli3-mediated balance between Fgfs and Wnts is of pivotal importance for the control of telencephalic patterning and axon tract formation, but very little is known about the molecular basis by which this balance is established and/or maintained. Here, we investigated direct interactions between Gli3 and these signaling pathways at the transcriptional level. We show that cortical hem activity of the Wnt8b dorsomedial telencephalon enhancer is positively regulated by Fgf signaling, while in turn Fgf17 expression is directly repressed by Wnt/β-catenin signaling. In addition, both signaling pathways cooperate in directly regulating Gli3 forebrain enhancer activity in the dorsomedial telencephalon. Taken together, these interactions form the basis of a key element regulating telencephalic patterning.
Differential Expression of Fgfs in the Telencephalon Coincides with Differences in Regulation and Functions
Multiple Fgfs with unique or redundant functions are involved in telencephalic patterning. Among the Fgf8/Fgf17/Fgf18 subfamily, Fgf8 is the key factor in telencephalic patterning (Hebert and Fishell 2008; Borello and Pierani 2010) , while Fgf17 has a more limited role in controlling the patterning of the rostral cortical primordium (Cholfin and Rubenstein 2007; Cholfin and Rubenstein 2008) . A role for Fgf18 in the rostral patterning center has not been established yet, but it has been implicated in controlling the migration of cortical neurons (Hasegawa et al. 2004 ). In contrast, Fgf15 opposes the function of Fgf8 (Borello et al. 2008) . This functional diversity is at least partially reflected in their complex and partially overlapping expression patterns, but little is known how this differential expression is established and maintained. Our analyses of Fgf gene expression in Gli3 mutants provided first insights into this regulation. While Fgf18 expression is not affected, Fgf8 and Fgf17 show a specific upregulation in dorsal midline tissues in the Gli3 mutants. In contrast, Fgf15 (C) and Ets 1+2 (D) constructs lack enhancer activity in the dorsomedial telencephalon and in the diencephalon. (E and F) Mutation of Ets-binding site 1 has no effect on enhancer activity (E), whereas embryos transgenic for the Gli3 reporter construct carrying a mutation in Ets-binding site 2 show no lacZ staining in the dorsomedial telencephalon and in the thalamus (F). Scale bars: 100 μm.
is ectopically expressed throughout the cortex of these mutants. These different effects of Gli3 mutations on Fgf gene expression suggest differential modes of transcriptional regulation. Due to their confined upregulation, Fgf8 and Fgf17 could be regulated by Bmp and/or Wnt/β-catenin signaling. Indeed, using bandshift and reporter gene analyses, we show that the activity of the intergenic Fgf17 forebrain enhancer is repressed in the dorsomedial telencephalon by Wnt/β-catenin signaling. In addition, pharmacological activation of Wnt/β-catenin signaling in an ex vivo explant assay resulted in a severe reduction of Fgf17 expression in the CP. Taken together with the ectopic Fgf17 expression in the Gli3 mutant dorsomedial telencephalon, this finding indicates that Fgf17 represents one of the few known directly repressed target genes for Wnt/β-catenin signaling. Interestingly, a second Fgf17 forebrain enhancer shows an overlapping activity in the septum, but is not active in the telencephalic roof plate consistent with the failure of GST-Lef1 protein to bind to a potential Tcf/Lef-binding site within this enhancer in our bandshift assay. While this lack of binding is likely to be explained by negative influences of neighboring sequences, the differential response of both enhancers to Wnt/β-catenin signaling suggests that the existence of both enhancers allowed the development of different regulatory output, while maintaining a core activity in the septum as has been reported for other shadow enhancers (Hong et al. 2008; Frankel et al. 2010; Perry et al. 2010 ). Regulation of Fgf8 expression in the forebrain appears to be even more complex. Recently, an extensive analysis of Fgf8 expression during embryogenesis revealed the existence of multiple enhancers distributed over a 200-kb stretch forming the Fgf8 holo-enhancer (Marinic et al. 2013) . In an identical enhancer assay to that used in our analysis, a couple of these elements (CE63 and CE64) display widespread activity in the telencephalon which only becomes confined to the CP by filtering through the holo-enhancer. Interestingly, our sequence analysis revealed several potential Tcf/Lef-binding sites in these 2 elements, suggesting that Wnt/ β-catenin signaling might be involved in regulating their activity and hence Fgf8 expression, but this hypothesis needs to be tested within the context of the holo-enhancer.
Fgf15 dramatically differs from other telencephalic Fgfs both in functional as well as in regulatory terms. Its activity as an Fgf8 antagonist coincides with a widespread upregulation throughout the dorsal telencephalon of the Gli3 mutants analyzed here and in Gli3
Xt/Xt mutants (Rash and Grove 2007) . This ectopic expression taken together with Fgf15 expression in the interganglionic sulcus where Shh signaling is active raised the possibility that Gli3 directly represses Fgf15 expression in the dorsal telencephalon. However, a mutation in a Gli-binding site which has previously been shown to be critical for the activity of an Fgf15 ventral midbrain/diencephalon enhancer did not result in reporter gene expression in the dorsal telencephalon. This finding suggests that different, currently unknown regulatory elements outside the promoter region may be responsible for this repression or that this repression is indirect. Regardless of the exact mechanism, the repression of Fgf15 expression by Gli3 is likely to be of functional importance since ectopic Fgf15 expression in the E14.5 dorsal telencephalon causes premature differentiation of cortical progenitors (Wilson et al. 2012 ), but may also limit the effects of ectopic Fgf8 expression in Gli3 mutants due to its antagonistic effects on Fgf8 (Borello et al. 2008) .
Fgf Signaling Regulates the Activity Levels of the Wnt8b Dorsomedial Enhancer
In addition to the direct repression of Fgf17 by Wnt/β-catenin signaling, we provide evidence that Fgf signaling in turn directly regulates Wnt8b expression in the cortical hem. The Wnt8b dorsomedial telencephalon enhancer contains an Ets-binding site mutation of which results in loss of enhancer activity in the hem. Moreover, ectopic expression of activator and repressor forms of the Etv4 transcription factors led to activation and repression of the Wnt8b enhancer in the rostromedial telencephalon, respectively. Taken together, these findings strongly suggest that Wnt8b is a direct target for Fgf signaling. Previously, it was shown that Wnt8b expression is repressed by Foxg1 via an evolutionarily conserved binding site in the Wnt8b promoter (Danesin et al. 2009 ) distinct from the Wnt8b dorsomedial telencephalon enhancer. Hence, Fgfs can regulate Wnt8b expression by 2 independent mechanisms, either directly via the Ets-binding site in the dorsomedial telencephalon enhancer or indirectly through Foxg1. The mutual interactions between Fgfs and Wnts form an important aspect of patterning. The rostral telencephalon is peculiar in that domains of Fgf15/17/18 and Wnt7b/Wnt8b expression are juxtaposed (Roy et al. 2014) . This juxtaposition combined with the mutual interactions provides a mechanism by which not only stable expression domains of these factors are generated, but which also limit the extent of Fgf and Wnt/β-catenin signaling. This mechanism appears of particular importance in light of the Wnt8b autoregulation (Hasenpusch-Theil et al. 2012). 
Fgf and Wnt/β-Catenin Signalling Cooperate in Regulating Gli3 Expression in the Dorsomedial Telencephalon
In addition to the mutual interactions between Fgf and Wnt/β-catenin signaling, both pathways cooperate in regulating the activity of the Gli3 forebrain enhancer. Previously, we showed that the activity of this enhancer depends on a Tcf/Lef-binding site (Hasenpusch-Theil et al. 2012) . Here, we extend this finding by showing Fgf signaling is also involved in regulating the activity of the Gli3 forebrain enhancer. While Ets-binding site 3 might have a modulatory effect, Ets-binding site 2 immediately adjacent to the Tcf-binding site is required for enhancer activity specifically both in the dorsomedial telencephalon and in the dorsal diencephalon. This spatially confined effect coincides with the known expression of Fgfs and with the activity of Fgf signaling in both tissues (Zimmer et al. 2010) . Moreover, the presence of Ets protein increases the binding of Lef1 protein to an oligonucleotide from the Gli3 enhancer in a bandshift assay. Interestingly, this increased binding does not result from the simultaneous binding of both transcription factors, suggesting that Etv4 might increase Lef1-binding activity in a DNA-independent manner. Taken together, these findings strongly suggest that both signaling pathways converge to regulate Gli3 expression in the dorsomedial telencephalon and dorsal diencephalon.
This cooperative interaction in the regulation of Gli3 expression combined with the mutual interactions between Fgf and Wnt/β-catenin signaling confers stability and robustness to the telencephalic patterning process. Based on genetic analyses, a model was proposed that unidentified factors promoting cortical specification in the dorsal telencephalon are controlled by Fgf activity, which in turn is disinhibited by Gli3 repressor-mediated inhibition of Fgf gene expression (Rash and Grove 2007) . Our analyses extend this model and clarify the molecular basis of some of these interactions (Fig. 7) . Due to their prominent role in dorsal telencephalic development (Machon et al. 2007; Mangale et al. 2008 ) and due to their direct control of Gli3 expression (Hasenpusch- , Wnts are likely to be at least one of the factors specifying cortical cell fates and directing early cortical differentiation. Direct regulation of Wnt8b expression in the hem by Fgf signaling and a mutual and direct repression of Fgf17 and possibly Fgf8 expression by Wnt/β-catenin signaling provide a balance between these 2 pathways. Moreover, Gli3 connects these 2 pathways with the third major signaling pathway, Shh signaling, and hence is a central factor in cortical patterning by suppressing ventral telencephalic cell fates and by promoting specification of dorsal telencephalic cell fates through its control of the expression of multiple Fgfs and Wnts. Thus, the interconnectedness between Gli3, Wnt, and Fgf genes takes center stage in conferring robustness to the telencephalic patterning process. This tight control is essential to cortical development since subtle changes in Fgf or Gli3 expression levels as in Fgf8 hypomorphic and Gli3
Pdn/Pdn mutants, respectively, or in the Gli3 activator/Gli3
repressor ratio as in ciliary mouse mutants can have profound effects not only on telencephalic patterning (Willaredt et al. 2008 ), but also on subsequent developmental processes. For example, small differences in Gli3 expression levels or in Gli3 processing have been hypothesized to form the basis for agenesis of the corpus callosum in GLI3 and ciliopathy patients (Benadiba et al. 2012; Amaniti et al. 2013; Magnani et al. 2014; Laclef et al. 2015) . Moreover, gradients of Fgf and Wnt signaling molecules are crucial determinants of cortical arealization and, based on the protomap hypothesis (Rakic 1988; 2009) , changes in the levels of Fgf and Wnt gene expression have been suggested to play an important role in the evolution of cortical areas. Our study provides a framework for understanding how these gradients are set up early in cortical development during regionalization of the dorsal telencephalon.
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